Skip to main content Skip to section navigation Skip to footer
Kazia Therapeutics Corporate homepage
  • About Us
    • Company Overview
    • Management
    • Board of Directors
  • Pipeline
    • Pipeline Overview
    • Paxalisib
    • PD-L1 Protein Degrader
    • SETDB1 Inhibitor
    • EVT801
    • Clinical Trials
    • Posters & Publications
  • Technology
  • Media Center
    • Media Center Overview
    • News
    • Events
    • In The News
    • Video Gallery
    • ASX Announcements
  • Investors
    • Investors Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
    • ASX Delisting
  • Contact Us

Section 16 Filings

Investors

  • Investors Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Annual General Meeting
    • Email Alerts
  • Company Info
    • Company Profile
    • Management
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • Quote & Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
  • Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • ASX Delisting
    • Conversion How-to
  • SEC Filings

  • All SEC Filings
  • Annual Reports
  • Section 16 Filings
SEC Filings
Date Form Description XBRL Pages
05/23/06 4 Form 4: Statement of changes in beneficial ownership of securities 2
05/11/06 4 Form 4: Statement of changes in beneficial ownership of securities 2
04/03/06 3 Form 3: Initial statement of beneficial ownership of securities 1
12/17/03 3 Form 3: Initial statement of beneficial ownership of securities 1
rss_feed Filing RSS
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 Kazia Therapeutics. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement